Literature DB >> 11395241

Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?

C Nieder1, V Gregoire, K K Ang.   

Abstract

PURPOSE: To review the value of extended diagnostic work-up procedures and to compare the results of comprehensive or volume-restricted radiotherapy in patients presenting with cervical lymph node metastases from clinically undetectable squamous cell carcinoma. METHODS AND MATERIALS: A systematic review was undertaken of published papers up to May 2000.
RESULTS: Positron emission tomography (PET) has an overall staging accuracy of 69%, with a positive predictive value of 56% and negative predictive value of 86%. With negative routine clinical examination and computerized tomography (CT) or magnetic resonance imaging (MRI), PET detected primary tumors in 5-25% of patients, whereas ipsilateral tonsillectomy discovered carcinoma in about 25% of patients. Laser-induced fluorescence imaging with panendoscopy and directed biopsies showed some encouraging preliminary results and warrants further study. All together, the reported mucosal carcinoma emergence rates were 2-13% (median, 9.5%) after comprehensive radiotherapy and 5-44% (median, 8%) after unilateral neck irradiation. The corresponding nodal relapse rates were 8-45% (median, 19%) and 31-63% (median, 51.5%), and 5-year survival rates were 34-63% (median, 50%) and 22-41% (median, 36.5%), respectively. Retrospective single-institution comparisons between comprehensive and unilateral neck radiotherapy did not show apparent differences in outcome. Prognostic determinants for survival are the N stage, number of nodes, extracapsular extension, and histologic grade. No data were found to support the benefit of chemotherapy in this disease.
CONCLUSION: Physical examination, CT or MRI, and panendoscopy with biopsies remain the standard work-up for these patients. Routine use of PET or laser-induced fluorescence imaging cannot be firmly advocated based on presently available data. Although combination of nodal dissection with comprehensive radiotherapy yielded most favorable results, its impact on the quality of life should be recognized, and the confounding effects of patient selection for various treatment modalities on therapeutic outcome cannot be ruled out. A randomized trial comparing the therapeutic value of comprehensive vs. volume-limited radiotherapy is being considered.

Entities:  

Mesh:

Year:  2001        PMID: 11395241     DOI: 10.1016/s0360-3016(01)01462-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  35 in total

1.  Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.

Authors:  Candan Demiroz; Jeffrey M Vainshtein; Georgios V Koukourakis; Orit Gutfeld; Mark E Prince; Carol R Bradford; Gregory T Wolf; Scott McLean; Francis P Worden; Douglas B Chepeha; Matthew J Schipper; Jonathan B McHugh
Journal:  Head Neck       Date:  2013-11-18       Impact factor: 3.147

2.  FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies.

Authors:  Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-29       Impact factor: 9.236

3.  Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.

Authors:  Müjdat Yildirim; Jens Müller von der Grün; Ria Winkelmann; Emmanouil Fokas; Franz Rödel; Hanns Ackermann; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2017-01-31       Impact factor: 3.621

4.  Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary.

Authors:  S Janssen; C Glanzmann; G Huber; G Studer
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

5.  p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary.

Authors:  Lanea M Keller; Thomas J Galloway; Thomas Holdbrook; Karen Ruth; Donghua Yang; Cara Dubyk; Douglas Flieder; Miriam N Lango; Ranee Mehra; Barbara Burtness; John A Ridge
Journal:  Head Neck       Date:  2014-01-13       Impact factor: 3.147

6.  Diagnosis and management of carcinoma of unknown primary in the head and neck.

Authors:  Wolfgang J Issing; Behsad Taleban; Stefan Tauber
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-04-09       Impact factor: 2.503

7.  Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy.

Authors:  John Cuaron; Shyam Rao; Suzanne Wolden; Michael Zelefsky; Karen Schupak; Borys Mychalczak; Nancy Lee
Journal:  Head Neck       Date:  2015-07-06       Impact factor: 3.147

Review 8.  Diagnosis and management of neck metastases from an unknown primary.

Authors:  L Calabrese; B A Jereczek-Fossa; J Jassem; A Rocca; R Bruschini; R Orecchia; F Chiesa
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

9.  Bilateral synchronous tonsillar carcinoma in cervical cancer of unknown primary site (CUPS).

Authors:  Ilkay Kazak; Andreas Haisch; Sergije Jovanovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-09       Impact factor: 2.503

10.  Metastatic squamous cell carcinoma neck with occult primary: A retrospective analysis.

Authors:  Pragya Shukla; Deepak Gupta; Shyam Singh Bisht; Mohan Chand Pant; Madan Lal Bhatt; Kirti Srivastava; Mahendra Pal Singh Negi
Journal:  Indian J Med Paediatr Oncol       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.